← Back to catalogue

GAL-1A Plus Blood Glucose Monitoring System

FDA 510(k)

Class II (US FDA 510(k))

510(k) K213887

by Apex Biotechnology Corp.

Identifiers

510(k) Number
K213887 FDA 510(k)
FDA Product Code
NBW FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 862.1345 FDA 510(k)
Regulation Number
862.1345 FDA 510(k)
Advisory Committee
Clinical Chemistry FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The GAL-1A Plus Blood Glucose Monitoring System is an in vitro diagnostic device classified as a blood glucose test system. It is designed for the quantitative measurement of glucose levels in fresh capillary whole blood obtained from the finger, intended for use outside the body. This system aids individuals with diabetes in monitoring blood glucose concentrations as part of home diabetes management. The device operates as a standalone system for self-testing purposes.

The system is supplied as a single-use device and is intended for use by patients at home. It is not intended for reusable applications or clinical settings outside of self-monitoring. The GAL-1A Plus has received FDA 510(k) clearance under Special Controls, classified under product code NBW. No additional regulatory details beyond the provided clearance are stated in the specifications.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: K213887 - GAL-1A Plus Blood Glucose Monitoring Sy..., GAL-1A Plus Blood Glucose Monitoring System (K213887 ... - fda ..., K113208 FDA 510(k) - GAL-1A BLOOD GLUCOSE MONITORING SYSTEM, GAL-1A Plus Blood Glucose Monitoring System - FDA 510(k) K213887

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K213887 24 fields · synced Oct 1, 2026